Clinical trials
Age clinical trials
Below are recruiting age clinical trials, each written for real people, not researchers. We’re tracking 1,307 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06732895RecruitingPhase 2
Weekly injection for teens with achondroplasia
This trial tests a weekly injection called navepegritide for adolescents aged 12-18 with achondroplasia (a common form of dwarfism). The goal is to see if it can safely improve growth. You must have a genetic confirmation of achondroplasia and a historical height measurement from the past 6 to 15 months.
MontrealAges 12–17 - NCT06735248RecruitingPhase 2
Study testing mRNA vaccine for multiple sclerosis relapse prevention
This study tests whether an mRNA vaccine (mRNA-1195) can help prevent relapses in people with early relapsing multiple sclerosis (MS). It compares the vaccine to a placebo (a shot with no active ingredient) to see if it is safe and effective.
Boston, MassachusettsAges 18–55 - NCT06740630RecruitingPhase 3
A chickenpox vaccine study for healthy toddlers 12 to 15 months old
This study tests an experimental chickenpox vaccine to see how well it works and if it's safe. Your child may be able to join if they are healthy and between 12 and 15 months old.
Mobile, AlabamaAges 1 year–1.3 years - NCT06742307RecruitingPhase 4
Faricimab quarterly shots for wet age-related macular degeneration
This trial tests if faricimab eye injections given every 3 months can keep wet age-related macular degeneration under control. It is for people with a new or returning active blood vessel growth in the center of the macula.
Hong KongAges 50 years+ - NCT06745609Recruiting
Prehabilitation before kidney tumor surgery
This trial tests whether a prehabilitation program (exercises and health support before surgery) can help older adults who are somewhat frail recover better after kidney tumor surgery.
HerlevAges 65 years+ - NCT06751836Recruiting
New ways to treat severe dengue
This trial tests new strategies to treat dengue, ranging from mild to severe cases. It may help people with different stages of dengue find better care and support.
Guatemala CityAges 18 years+ - NCT06751992RecruitingPhase 4
Thinking and memory with extended-release tacrolimus in kidney transplant
This study tests if switching to an extended-release form of your anti-rejection medication (tacrolimus) helps protect memory and thinking skills. It is for older adults who have had a kidney transplant at least one year ago.
Boston, MassachusettsAges 65 years+ - NCT06754202Recruiting
Farming and nature activities for mild memory loss
This study tests if spending time in farmlands and natural settings can help older adults with mild memory problems maintain their thinking abilities and overall health. It uses a special approach based on the Montessori method to keep participants engaged and active.
AnconaAges 55 years+ - NCT06756269RecruitingPhase 2
HPV vaccine study for people aged 9 to 45
This trial tests a new 15-valent HPV vaccine to see if it is safe and creates a strong immune response. If you are between 9 and 45 years old and have not had an HPV vaccine before, you may be able to join.
Nanning, GuangxiAges 9–45 - NCT06764810Recruiting
Motor skills and senses in children 4–11
This study looks at how motor skills (like catching, jumping) and sensory processing (how the brain handles sights, sounds, touch) are related in children with and without certain developmental differences. The goal is to better understand these connections to help support children's development.
VicAges 4–11 - NCT06767410Recruiting
A program to support healthy aging in older adults
This study tests a multi-domain intervention (combining different healthy habits like physical, mental, and social activities) to see if it helps older adults age well. You may join if you are 65 or older and live on your own.
Adelfia, BariAges 65 years+ - NCT06769633RecruitingPhase 2
Study of givinostat in young boys with Duchenne muscular dystrophy
This trial tests an experimental drug called givinostat in boys ages 2 to under 6 years with Duchenne muscular dystrophy (DMD). The study looks at how the drug works in the body and if it is safe, with the goal of finding new treatment options for young children.
BrusselsAges 2–6 - NCT06769659RecruitingPhase 2
Testing NPT 2042 for absence seizures in genetic epilepsy
This trial tests a new medication called NPT 2042 for people with a type of epilepsy that causes brief staring spells (absence seizures). It aims to see if the drug can reduce seizure frequency compared to a placebo (an inactive pill).
Little Rock, ArkansasAges 16–75 - NCT06774586Recruiting
Study of blood vessel health in children
This study examines the health of blood vessels in children ages 6 to 17, using a non-invasive device called Vicorder to measure vessel stiffness. It aims to understand how blood vessel walls work in youth.
BolognaAges 6–17 - NCT06776133Recruiting
Predicting heart pressure from vein size in children
This study looks at a possible link between the size of a large vein (the inferior vena cava) and the pressure in the right side of the heart in children. If the link is strong, doctors might one day use vein size to estimate heart pressure without more invasive tests.
Bologna, BolognaAges Up to 18 years - NCT06780917Recruiting
Online cognitive testing for older adults with depression or memory concerns
This study tests whether an online cognitive assessment platform (Creyos) is valid for older adults with major depression or mild cognitive impairment. Participants will complete brain games or puzzles to see how well the online tool measures thinking skills.
Toronto, OntarioAges 60 years+ - NCT06787482RecruitingPhase 1/Phase 2
Peptide therapy for retinitis pigmentosa
This trial tests a new peptide therapy for people with retinitis pigmentosa (RP), a genetic eye disease that causes vision loss. The goal is to see if the treatment is safe and can help slow or improve vision loss.
CairoAges Any age - NCT06792877Recruiting
Mindfulness for thinking in early Alzheimer's
This study tests if mindfulness training can help protect thinking and memory in early-stage Alzheimer's disease. It compares mindfulness to other activities to see if it slows down memory loss.
Boston, MassachusettsAges 50–100 - NCT06793072Recruiting
Adipokines in PCOS trial
This study looks at certain proteins (adipokines) in the blood of people with polycystic ovary syndrome (PCOS) to see how they relate to the condition. It may help researchers better understand PCOS.
KrakowAges 18–45 - NCT06793085Recruiting
Inflammation Proteins in PCOS Study
This study looks at inflammation-related proteins in women with PCOS to understand what causes the condition. If eligible, you’d help researchers learn more about PCOS, which could lead to better treatments.
KrakowAges 18–45 - NCT06793098Recruiting
Functional proteins in polycystic ovary syndrome
This study measures proteins in the blood that may be linked to polycystic ovary syndrome (PCOS). It aims to find differences between women with PCOS and those without, which could lead to better understanding and diagnosis.
KrakowAges 18–45 - NCT06793501Recruiting
Reablement program for older adults in nursing homes
This trial tests a reablement program to help older adults in nursing homes maintain or improve their daily function and independence. If you live in a somatic ward in one of the participating facilities, can converse in Swedish, and are not severely cognitively impaired or very frail, you might be able to join.
Örebro, Örebro CountyAges 65 years+ - NCT06794879Recruiting
Parent survey on children's pain and sedation
This trial asks parents to fill out a survey about how their child's pain and sedation are managed during blood draws or other procedures. The goal is to understand parents' views and improve care for children.
Bologna, ItalyAges Any age - NCT06797908Recruiting
High Blood Pressure in Children and Teens
This study looks at high blood pressure in children and teens. It aims to understand how to manage it in young people under 18.
Bologna, BolognaAges Up to 18 years
Hear when a new Age trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for age?
- Yes. Clin2 currently lists 1,307 recruiting age studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a age trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a age trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.